Latest news
Maxim Group Maintains Coherus Oncology(CHRS.US) With Buy Rating, Maintains Target Price $4 - MoomooMoomoo · Sat, 08 Aug 2026 00:32:08 GMTCHRS Maintained by Guggenheim -- Price Target Lowered to $10.00 - GuruFocusGuruFocus · Fri, 07 Aug 2026 19:09:08 GMTsymbol__ Stock Quote Price and Forecast - CNNCNN · Thu, 06 Aug 2026 17:35:17 GMTCoherus Oncology, Inc. Q2 2026 Earnings Call Summary - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 12:30:00 GMTCoherus Oncology, Inc. (CHRS) stock price, news, quote and history - Yahoo Finance AustraliaYahoo Finance Australia · Thu, 06 Aug 2026 08:22:32 GMTCoherus Oncology Inc (CHRS) (Q2 2026) Earnings Call Highlights: - GuruFocusGuruFocus · Thu, 06 Aug 2026 06:22:30 GMTCoherus Oncology, Inc. 2026 Q2 10-Q Highlights: Financials, Risks, and Forward-Looking Statements for Investors - MinichartMinichart · Thu, 06 Aug 2026 04:02:00 GMTCHRS Looks 83.5% Overvalued on GF Value™ - GuruFocusGuruFocus · Thu, 06 Aug 2026 00:49:04 GMT